Cargando…
Treatment with Methotrexate and Intravenous Cyclophosphamide Pulse Therapy Regulates the P-gp(+)CD4(+) Cell-related Pathogenesis in a Representative Patient with Refractory Proliferative Lupus Nephritis
Diffuse proliferative lupus nephritis (DPLN) is a serious organ complication. Drug resistance correlates with P-glycoprotein (P-gp) expression on activated lymphocytes. We encountered a refractory DPLN patient with expansion of peripheral CD69/CXCR3-co-expressing P-gp(+)CD4(+) cells producing IL-2 a...
Autores principales: | Tsujimura, Shizuyo, Tanaka, Yoshiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875445/ https://www.ncbi.nlm.nih.gov/pubmed/31685786 http://dx.doi.org/10.2169/internalmedicine.2589-18 |
Ejemplares similares
-
Efficacy of Intravenous Cyclophosphamide Pulse Therapy for P-Glycoprotein-expressing B Cell-associated Active True Renal Lupus Vasculitis in Lupus Nephritis
por: Kawabe, Akio, et al.
Publicado: (2017) -
Role of P-glycoprotein on CD69(+)CD4(+) cells in the pathogenesis of proliferative lupus nephritis and non-responsiveness to immunosuppressive therapy
por: Tsujimura, Shizuyo, et al.
Publicado: (2017) -
The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011) -
A Randomized Controlled Trial Comparing Remission Induction with Modified Multitarget Therapy with Intravenous Cyclophosphamide in Proliferative Lupus Nephritis
por: Pal, Atanu, et al.
Publicado: (2023) -
Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis
por: Vachvanichsanong, Prayong, et al.
Publicado: (2012)